Politics
Drug groups warn US pricing policy is choking off new medicines in Sweden [Advocacy Lab]
The need for clarity on Swedish pricing and reimbursement has put new medicine launches on hold
This story was reported by Euractiv. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Euractiv →